151 related articles for article (PubMed ID: 31838744)
1. Radionuclide spatial distribution and dose deposition for in vitro assessments of
Frelin-Labalme AM; Roger T; Falzone N; Quan Lee B; Sibson NR; Vallis KA; Bernaudin M; Valable S; Corroyer-Dulmont A
Med Phys; 2020 Mar; 47(3):1317-1326. PubMed ID: 31838744
[TBL] [Abstract][Full Text] [Related]
2. Application of a new spectral deconvolution method for in vitro dosimetry in assessment of targeted alpha therapy.
Doudard A; Corroyer-Dulmont A; Jaudet C; Bernaudin M; Valable S; Ledoux X; Frelin-Labalme AM
Med Phys; 2023 Jun; 50(6):3762-3772. PubMed ID: 36734667
[TBL] [Abstract][Full Text] [Related]
3. A diffusion-leakage model coupled with dose point kernels (DPK) for dosimetry of diffusing alpha-emitters radiation therapy (DaRT).
Khan AU; Jollota S; DeWerd LA
Med Phys; 2024 May; 51(5):3725-3733. PubMed ID: 38284426
[TBL] [Abstract][Full Text] [Related]
4. Modeling Cell and Tumor-Metastasis Dosimetry with the Particle and Heavy Ion Transport Code System (PHITS) Software for Targeted Alpha-Particle Radionuclide Therapy.
Lee D; Li M; Bednarz B; Schultz MK
Radiat Res; 2018 Sep; 190(3):236-247. PubMed ID: 29944461
[TBL] [Abstract][Full Text] [Related]
5. VCAM-1 targeted alpha-particle therapy for early brain metastases.
Corroyer-Dulmont A; Valable S; Falzone N; Frelin-Labalme AM; Tietz O; Toutain J; Soto MS; Divoux D; Chazalviel L; Pérès EA; Sibson NR; Vallis KA; Bernaudin M
Neuro Oncol; 2020 Mar; 22(3):357-368. PubMed ID: 31538194
[TBL] [Abstract][Full Text] [Related]
6. Development of a stand-alone precalculated Monte Carlo code to calculate the dose by alpha and beta emitters from the Ra-224 decay chain.
Hoseini-Ghahfarokhi M; Kamio Y; Mondor J; Jabbari K; Carrier JF
Med Phys; 2023 Aug; 50(8):5176-5188. PubMed ID: 37161766
[TBL] [Abstract][Full Text] [Related]
7.
Li M; Sagastume EA; Lee D; McAlister D; DeGraffenreid AJ; Olewine KR; Graves S; Copping R; Mirzadeh S; Zimmerman BE; Larsen RH; Johnson FL; Schultz MK
Curr Med Chem; 2020; 27(41):7003-7031. PubMed ID: 32720598
[TBL] [Abstract][Full Text] [Related]
8. Dosimetry in targeted alpha therapy. A systematic review: current findings and what is needed.
Tronchin S; Forster JC; Hickson K; Bezak E
Phys Med Biol; 2022 Apr; 67(9):. PubMed ID: 35316802
[No Abstract] [Full Text] [Related]
9. Solid-tumor radionuclide therapy dosimetry: new paradigms in view of tumor microenvironment and angiogenesis.
Zhu X; Palmer MR; Makrigiorgos GM; Kassis AI
Med Phys; 2010 Jun; 37(6):2974-84. PubMed ID: 20632610
[TBL] [Abstract][Full Text] [Related]
10. Development and dosimetry of
Dos Santos JC; Schäfer M; Bauder-Wüst U; Lehnert W; Leotta K; Morgenstern A; Kopka K; Haberkorn U; Mier W; Kratochwil C
Eur J Nucl Med Mol Imaging; 2019 May; 46(5):1081-1091. PubMed ID: 30603987
[TBL] [Abstract][Full Text] [Related]
11. Targeted alpha therapy: part I.
Elgqvist J
Curr Radiopharm; 2011 Jul; 4(3):176. PubMed ID: 22201706
[TBL] [Abstract][Full Text] [Related]
12. Targeted alpha therapy with
Ackerman NL; de la Fuente Rosales L; Falzone N; Vallis KA; Bernal MA
Phys Med; 2018 Jul; 51():91-98. PubMed ID: 29807854
[TBL] [Abstract][Full Text] [Related]
13. Effect of microdistribution of alpha and beta-emitters in targeted radionuclide therapies on delivered absorbed dose in a GATE model of bone marrow.
Tranel J; Feng FY; James SS; Hope TA
Phys Med Biol; 2021 Jan; 66(3):035016. PubMed ID: 33321484
[TBL] [Abstract][Full Text] [Related]
14. A Monte Carlo Method for Determining the Response Relationship between Two Commonly Used Detectors to Indirectly Measure Alpha Particle Radiation Activity.
Tichacek CJ; Budzevich MM; Wadas TJ; Morse DL; Moros EG
Molecules; 2019 Sep; 24(18):. PubMed ID: 31546752
[TBL] [Abstract][Full Text] [Related]
15. Monte Carlo dosimetry of a realistic multicellular model of follicular lymphoma in a context of radioimmunotherapy.
Bordes J; Incerti S; Mora-Ramirez E; Tranel J; Rossi C; Bezombes C; Bordenave J; Bardiès M; Brown R; Bordage MC
Med Phys; 2020 Oct; 47(10):5222-5234. PubMed ID: 32623743
[TBL] [Abstract][Full Text] [Related]
16. Development of a transmission alpha particle dosimetry technique using A549 cells and a Ra-223 source for targeted alpha therapy.
Al Darwish R; Staudacher AH; Li Y; Brown MP; Bezak E
Med Phys; 2016 Nov; 43(11):6145. PubMed ID: 27806616
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric evaluation of radionuclides for VCAM-1-targeted radionuclide therapy of early brain metastases.
Falzone N; Ackerman NL; Rosales LF; Bernal MA; Liu X; Peeters SG; Soto MS; Corroyer-Dulmont A; Bernaudin M; Grimoin E; Touzani O; Sibson NR; Vallis KA
Theranostics; 2018; 8(1):292-303. PubMed ID: 29290808
[TBL] [Abstract][Full Text] [Related]
18. Comparison between Targeted Radionuclide Therapy of Bone Metastases Based on β-Emitting and α-Emitting Radionuclides.
Sadremomtaz A; Masoumi M
J Med Imaging Radiat Sci; 2019 Jun; 50(2):272-279. PubMed ID: 31176435
[TBL] [Abstract][Full Text] [Related]
19. Experimental validation of Monte Carlo dosimetry for therapeutic beta emitters with radiochromic film in a 3D-printed phantom.
Van B; Dewaraja YK; Niedbala JT; Rosebush G; Kazmierski M; Hubers D; Mikell JK; Wilderman SJ
Med Phys; 2023 Jan; 50(1):540-556. PubMed ID: 35983857
[TBL] [Abstract][Full Text] [Related]
20. A nephron-based model of the kidneys for macro-to-micro α-particle dosimetry.
Hobbs RF; Song H; Huso DL; Sundel MH; Sgouros G
Phys Med Biol; 2012 Jul; 57(13):4403-24. PubMed ID: 22705986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
